Laboratory News and Research

RSS

Recently discovered protein may play key role in obesity and metabolic disease

With unexpected findings about a protein that's highly expressed in fat tissue, scientists at Scripps Research have opened the door to critical new understandings about obesity and metabolism.

21 Nov 2019

What causes harsher parenting by alcoholic women?

A new study tells us more about what presses the trigger when it comes to harsh parenting by alcohol-dependent mothers.

21 Nov 2019

Machine learning successfully replicates cell architecture

A new study reports the use of machine learning to help form complex cell architectures from pluripotent stem cells.

21 Nov 2019

Researchers identify a promising drug pair to attack deadly childhood brain cancers

Researchers have devised a new plan of attack against a group of deadly childhood brain cancers collectively called diffuse midline gliomas, including diffuse intrinsic pontine glioma, thalamic glioma and spinal cord glioma.

20 Nov 2019

Traditional ways of learning anatomy remain superior than virtual and mixed reality models

A study from McMaster University has shown that traditional ways of learning anatomy remain superior to those that rely on digital media.

20 Nov 2019

Novel microscope optimizes illumination to improve diagnosis

Engineers at Duke University have developed a microscope that adapts its lighting angles, colors and patterns while teaching itself the optimal settings needed to complete a given diagnostic task.

20 Nov 2019

Newly developed ChiTaRS database can collect cases of druggable fusion targets

When sections from two separate genes merge due to various factors, such as translocation or splicing, the hybrid that is formed is called a gene fusion. In recent years, it has been discovered that these fusion events play a vital role in the development of cancers and other complex diseases.

20 Nov 2019

Fosun Pharma, MimiVax to jointly develop and commercialize SurVaxM therapy in U.S.

The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert Fenstermaker, MD, and Michael Ciesielski, PhD, have announced that the company, spun off from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for SurVaxM with Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical Co. Ltd. based in Shanghai, China.

20 Nov 2019

Innovative technology may prevent hearing loss in military working dogs

Military working dogs played a vital role in the recent raid and death of ISIS leader Abu Bakr al-Baghdadi; however, temporary and permanent hearing loss due to high-decibel noise in training, transport and operations put these animals at risk.

20 Nov 2019

Applying a Proteomics-based Approach to the Clinic

Matthias Mann explains why applying proteomics-based technologies such as timsTOF could accelerate the diagnosis and prediction of human disease.

From Bruker Daltonics 20 Nov 2019

Rheumatoid arthritis linked to other diseases before and after diagnosis, shows study

A Mayo Clinic-led study involving 3,276 patients has found that people with inflammatory bowel disease, Type 1 diabetes or blood clots may be at increased risk of developing rheumatoid arthritis.

20 Nov 2019

New brain research by UTHealth student was showcased at Neuroscience 2019

Brain research by a student in a laboratory at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth) was singled out for special attention at the Society for Neuroscience (SfN) annual meeting in Chicago Oct. 19-23.

20 Nov 2019

E-meditation: Coupling cutting-edge brain stimulation with mindfulness

We live in a society plagued by burnout. Our hyper-connectivity, sustained through the pulse of WiFi, leaves little room for quiet. This constant stimulation can cause stress, which is a risk factor for a host of diseases, including diabetes, depression and heart disease.

19 Nov 2019

Depression puts teen girls in South Africa at higher risk of HIV infection

Teen girls in South Africa face an extraordinary threat of HIV: By the time they reach adulthood, one in four South African girls will have contracted the virus, and most are first infected during adolescence.

19 Nov 2019

Malaria research advances immunotherapy in lupus, HIV

A new study published on November 19, 2019, in the journal Cell Reports, shows how the body’s immune system responds to malaria, which in turn promises to teach scientists how to design more effective therapies for a range of illnesses that are modulated by the immune response.

19 Nov 2019

Teenage binge drinking may lead to anxiety and alcohol abuse in later life

Exposure to high levels of alcohol in adolescence may shape adult behaviors, predisposing them to a higher risk of anxiety and alcohol abuse later in life, a new study found.

19 Nov 2019

Study provides insight into harsh parenting by alcohol-dependent mothers

Not surprisingly, parents with substance use disorders often struggle with parenting and frequently have strained relationships with their children.

19 Nov 2019

Miniscule robots like "Magic School Bus" could clear blood clots

Pulmonary embolism is a condition where a clot forms and blocks the arteries of the lungs and this restricts the blood flow to the lungs and lowers the amount of oxygen reaching the different organs. Statistics from the National Institutes of Health show that pulmonary embolism leads to nearly 200,000 to 300,000 deaths in the United States annually putting it at number three in cardiovascular diseases right after heart attack and stroke.

19 Nov 2019

Scientists develop new therapy for acute myeloid leukemia

Cold Spring Harbor Laboratory scientists, with chemists and cancer biologists from Dana-Farber Cancer Institute, have developed a new therapy that extended the survival of mice with acute myeloid leukemia.

19 Nov 2019

Ketamine can decrease alcohol consumption in men, reveal FSU researchers

Research from Florida State University is giving physicians a better understanding of ketamine, a potentially useful tool in treating depression that still has unanswered questions.

19 Nov 2019